Scientists found a 22 percent lower risk of any dementia and Parkinson's among a group taking SGLT2 inhibitors for type 2 ...

The cause of Parkinson's Disease remains largely unknown, but a new drug could be extremely beneficial to treat symptoms.

Researchers have found that people who take a type of type 2 diabetes drugs SGLT2 inhibitors have a significantly lower risk ...

The NHS has committed to ending deadly delays in giving “time critical” medication to Parkinson’s patients in hospital, The ...

According to a new study, certain diabetes medications may significantly reduce this risk. These drugs, called gliflozins or ...

A specific class of diabetes drug appears to lower people's risk for dementia and Parkinson's disease, a new study shows.

Exercise is known as one of the best weapons in limiting the effects of the disease and creating dopamine that is low for ...

It could be a medical condition called essential tremor, and a new study by Singapore’s National Neuroscience Institute has ...

A new study shows that coffee is among the most commonly used "natural health products" used by people with Parkinson's ...

Gliflozins, another name for sodium-glucose cotransporter-2 (SGLT2) inhibitors, were the subject of the investigation. By ...

Increased exposure to air pollution in the form of particulate matter with a diameter of 2.5 µm or less (PM2.5) and nitrogen ...

The Fox News Health Newsletter brings you trending and important stories about health warnings, drug shortages, mental health ...